Cordlife

Cordlife: China Cord Blood (CO US) reported 4Q revenue that rose 33% yoy to US$21.4m. Operating income jumped 46% to US$8.2m, as gross margins edged up to 79.8% vs 76.6% yoy. The group added 16,059 new subscribers in 4Q, although mgt cautioned near term pressure to subscriber growth rates. Cordlife owns a 10% stake in China Cord Blood; is up 1.2% at $0.88.